1
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2021. CA Cancer J Clin. 71:7–33. 2021.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Sanli O, Dobruch J, Knowles MA, Burger M,
Alemozaffar M, Nielsen ME and Lotan Y: Bladder cancer. Nat Rev Dis
Primers. 3:170222017. View Article : Google Scholar : PubMed/NCBI
|
3
|
Minato A, Fujimoto N and Kubo T: Squamous
differentiation predicts poor response to cisplatin-based
chemotherapy and unfavorable prognosis in urothelial carcinoma of
the urinary bladder. Clin Genitourin Cancer. 15:e1063–e1067. 2017.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
5
|
Yang WS, SriRamaratnam R, Welsch ME,
Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji
AF, Clish CB, et al: Regulation of ferroptotic cancer cell death by
GPX4. Cell. 156:317–331. 2014. View Article : Google Scholar : PubMed/NCBI
|
6
|
Jariwala N, Rajasekaran D, Srivastava J,
Gredler R, Akiel MA, Robertson CL, Emdad L, Fisher PB and Sarkar D:
Role of the staphylococcal nuclease and tudor domain containing 1
in oncogenesis (review). Int J Oncol. 46:465–473. 2015. View Article : Google Scholar : PubMed/NCBI
|
7
|
Caudy AA, Ketting RF, Hammond SM, Denli
AM, Bathoorn AM, Tops BB, Silva JM, Myers MM, Hannon GJ and
Plasterk RH: A micrococcal nuclease homologue in RNAi effector
complexes. Nature. 425:411–414. 2003. View Article : Google Scholar : PubMed/NCBI
|
8
|
Zagryazhskaya A, Surova O, Akbar NS,
Allavena G, Gyuraszova K, Zborovskaya IB, Tchevkina EM and
Zhivotovsky B: Tudor staphylococcal nuclease drives chemoresistance
of non-small cell lung carcinoma cells by regulating S100A11.
Oncotarget. 6:12156–12173. 2015. View Article : Google Scholar : PubMed/NCBI
|
9
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Ogata H, Goto S, Sato K, Fujibuchi W, Bono
H and Kanehisa M: KEGG: Kyoto encyclopedia of genes and genomes.
Nucleic Acids Res. 27:29–34. 1999. View Article : Google Scholar : PubMed/NCBI
|
11
|
Cappellari M, Bielli P, Paronetto MP,
Ciccosanti F, Fimia GM, Saarikettu J, Silvennoinen O and Sette C:
The transcriptional co-activator SND1 is a novel regulator of
alternative splicing in prostate cancer cells. Oncogene.
33:3794–3802. 2014. View Article : Google Scholar : PubMed/NCBI
|
12
|
McKnight JJ, Gray SB, O'Kane HF, Johnston
SR and Williamson KE: Apoptosis and chemotherapy for bladder
cancer. J Urol. 173:683–690. 2005. View Article : Google Scholar : PubMed/NCBI
|
13
|
Cai Z, Zhang F, Chen W, Zhang J and Li H:
miRNAs: A promising target in the chemoresistance of bladder
cancer. Onco Targets Ther. 12:11805–11816. 2019. View Article : Google Scholar : PubMed/NCBI
|
14
|
Mou Y, Wang J, Wu J, He D, Zhang C, Duan C
and Li B: Ferroptosis, a new form of cell death: Opportunities and
challenges in cancer. J Hematol Oncol. 12:342019. View Article : Google Scholar : PubMed/NCBI
|
15
|
Ochoa B, Chico Y and Martinez MJ: Insights
into SND1 oncogene promoter regulation. Front Oncol. 8:6062018.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Tong X, Drapkin R, Yalamanchili R,
Mosialos G and Kieff E: The Epstein-Barr virus nuclear protein 2
acidic domain forms a complex with a novel cellular coactivator
that can interact with TFIIE. Mol Cell Biol. 15:4735–4744. 1995.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Wright T, Wang Y and Bedford MT: The role
of the PRMT5-SND1 axis in hepatocellular carcinoma. Epigenomes.
5:22021. View Article : Google Scholar : PubMed/NCBI
|
18
|
Zhan F, Zhong Y, Qin Y, Li L, Wu W and Yao
M: SND1 facilitates the invasion and migration of cervical cancer
cells by Smurf1-mediated degradation of FOXA2. Exp Cell Res.
388:1118092020. View Article : Google Scholar : PubMed/NCBI
|
19
|
Yu L, Liu X, Cui K, Di Y, Xin L, Sun X,
Zhang W, Yang X, Wei M, Yao Z and Yang J: SND1 acts downstream of
TGFβ1 and upstream of smurf1 to promote breast cancer metastasis.
Cancer Res. 75:1275–1286. 2015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Cui X, Zhang X, Liu M, Zhao C, Zhang N,
Ren Y, Su C, Zhang W, Sun X, He J, et al: A pan-cancer analysis of
the oncogenic role of staphylococcal nuclease domain-containing
protein 1 (SND1) in human tumors. Genomics. 112:3958–3967. 2020.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Gutierrez-Beltran E, Denisenko TV,
Zhivotovsky B and Bozhkov PV: Tudor staphylococcal nuclease:
Biochemistry and functions. Cell Death Differ. 23:1739–1748. 2016.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Cui X, Zhao C, Yao X, Qian B, Su C, Ren Y,
Yao Z, Gao X and Yang J: SND1 acts as an anti-apoptotic factor via
regulating the expression of lncRNA UCA1 in hepatocellular
carcinoma. RNA Biol. 15:1364–1375. 2018. View Article : Google Scholar : PubMed/NCBI
|
23
|
Hassannia B, Vandenabeele P and Vanden
Berghe T: Targeting ferroptosis to iron out cancer. Cancer Cell.
35:830–849. 2019. View Article : Google Scholar : PubMed/NCBI
|
24
|
Guo J, Xu B, Han Q, Zhou H, Xia Y, Gong C,
Dai X, Li Z and Wu G: Ferroptosis: A novel anti-tumor action for
cisplatin. Cancer Res Treat. 50:445–460. 2018. View Article : Google Scholar : PubMed/NCBI
|
25
|
Shi Z, Zhang L, Zheng J, Sun H and Shao C:
Ferroptosis: Biochemistry and biology in cancers. Front Oncol.
11:5792862021. View Article : Google Scholar : PubMed/NCBI
|
26
|
Song X, Wang X, Liu Z and Yu Z: Role of
GPX4-mediated ferroptosis in the sensitivity of triple negative
breast cancer cells to gefitinib. Front Oncol. 10:5974342020.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Zhang X, Sui S, Wang L, Li H, Zhang L, Xu
S and Zheng X: Inhibition of tumor propellant glutathione
peroxidase 4 induces ferroptosis in cancer cells and enhances
anticancer effect of cisplatin. J Cell Physiol. 235:3425–3437.
2020. View Article : Google Scholar : PubMed/NCBI
|
28
|
Ufer C, Wang CC, Fähling M, Schiebel H,
Thiele BJ, Billett EE, Kuhn H and Borchert A: Translational
regulation of glutathione peroxidase 4 expression through
guanine-rich sequence-binding factor 1 is essential for embryonic
brain development. Genes Dev. 22:1838–1850. 2008. View Article : Google Scholar : PubMed/NCBI
|
29
|
Wang Q, Guo Y, Wang W, Liu B, Yang G, Xu
Z, Li J and Liu Z: RNA binding protein DAZAP1 promotes HCC
progression and regulates ferroptosis by interacting with SLC7A11
mRNA. Exp Cell Res. 399:1124532021. View Article : Google Scholar : PubMed/NCBI
|
30
|
Kinzy SA, Caban K and Copeland PR:
Characterization of the SECIS binding protein 2 complex required
for the co-translational insertion of selenocysteine in mammals.
Nucleic Acids Res. 33:5172–5180. 2005. View Article : Google Scholar : PubMed/NCBI
|
31
|
Xie M, Huang P, Wu T, Chen L and Guo R:
Inhibition of miR-214-3p protects endothelial cells from
ox-LDL-induced damage by targeting GPX4. Biomed Res Int.
2021:99197292021. View Article : Google Scholar : PubMed/NCBI
|
32
|
Li G, Jin J, Liu S, Ding K and Qian C:
Inhibition of miR-1224 suppresses hypoxia/reoxygenation-induced
oxidative stress and apoptosis in cardiomyocytes through targeting
GPX4. Exp Mol Pathol. 121:1046452021. View Article : Google Scholar : PubMed/NCBI
|
33
|
Hou Y, Cai S, Yu S and Lin H: Metformin
induces ferroptosis by targeting miR-324-3p/GPX4 axis in breast
cancer. Acta Biochim Biophys Sin (Shanghai). 53:333–341. 2021.
View Article : Google Scholar : PubMed/NCBI
|
34
|
Xu Q, Zhou L, Yang G, Meng F, Wan Y, Wang
L and Zhang L: CircIL4R facilitates the tumorigenesis and inhibits
ferroptosis in hepatocellular carcinoma by regulating the
miR-541-3p/GPX4 axis. Cell Biol Int. 44:2344–2356. 2020. View Article : Google Scholar : PubMed/NCBI
|
35
|
Armengol S, Arretxe E, Rodriguez L, Ochoa
B, Chico Y and Martinez MJ: NF-κB, Sp1 and NF-Y as transcriptional
regulators of human SND1 gene. Biochimie. 95:735–742. 2013.
View Article : Google Scholar : PubMed/NCBI
|
36
|
Chen HH and Kuo MT: Overcoming platinum
drug resistance with copper-lowering agents. Anticancer Res.
33:4157–4161. 2013.PubMed/NCBI
|